Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank

@inproceedings{Caster2014ImprovedSS,
  title={Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank},
  author={Ola Caster and Kristina Juhlin and Sarah Watson and G. Niklas Nor{\'e}n},
  booktitle={Drug safety},
  year={2014}
}
BACKGROUND Detection of unknown risks with marketed medicines is key to securing the optimal care of individual patients and to reducing the societal burden from adverse drug reactions. Large collections of individual case reports remain the primary source of information and require effective analytics to guide clinical assessors towards likely drug safety signals. Disproportionality analysis is based solely on aggregate numbers of reports and naively disregards report quality and content… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
19 Citations
36 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

VigiBase, the WHO global ICSR database system: basic facts

  • M. Lindquist
  • Drug Inf J. 2008;42(5):409–19
  • 2008
Highly Influential
10 Excerpts

Similar Papers

Loading similar papers…